Truist Calls Cimpress N.V. (CMPR) an 'Attractive GARPY Story for Patient Investors'
Tweet Send to a Friend
Truist Securities analyst Youssef Squali reiterated a Buy rating and $87.00 price target on Cimpress N.V. (NASDAQ: CMPR).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
